about
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.
Read More
1.72
-0.08
(-4.44%)
9,879
XNAS Volume
XNAS 29 Aug, 2025 5:30 PM (EDT)
Board Meeting
The latest board meeting for BeyondSpring Inc took place on 29 Aug 2025, for the purpose of BeyondSpring Inc Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
BeyondSpring Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..